Study of Blood Samples From Newborns With Down Syndrome
Completed
Conditions studied: Myeloid Proliferations Associated With Down Syndrome
In brief
This research study is looking at blood samples from newborns with Down syndrome. Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.
Key facts
- Study ID
- NCT00959283
- Run by
- Children's Oncology Group
- People needed
- 180
- Starts
- 2009-02-23
- Expected to finish
- 2023-09-30
- Last updated by the study team
- 2023-10-03
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of transient myeloproliferative disorder (TMD) at < 90 days of age and meeting 1 of the following criteria:
- A diagnosis of Down syndrome or Down syndrome mosaicism AND non-erythroid and non-lymphoid blasts (any amount) in the peripheral blood verified with a second sample
- Patients with typical physical characteristics of Down syndrome are allowed before cytogenetic or FISH confirmation of the diagnosis
- Trisomy 21-positive leukemic blasts documented by biopsy of any organ (including > 5% non-erythroid/non-lymphoid blasts documented by bone marrow aspirate or biopsy)
- Infants with isolated trisomy 21 positivity identified only in the leukemic blasts are allowed
- Institutional immunophenotype characterization is required for study enrollment
Where it is running
- University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States
- USA Health Strada Patient Care Center — Mobile, Alabama, United States
- Providence Alaska Medical Center — Anchorage, Alaska, United States
- Phoenix Childrens Hospital — Phoenix, Arizona, United States
- Arkansas Children's Hospital — Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center — Downey, California, United States
- Loma Linda University Medical Center — Loma Linda, California, United States
- Miller Children's and Women's Hospital Long Beach — Long Beach, California, United States
- Children's Hospital Los Angeles — Los Angeles, California, United States
- Cedars Sinai Medical Center — Los Angeles, California, United States
- Mattel Children's Hospital UCLA — Los Angeles, California, United States
- UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California, United States
- Valley Children's Hospital — Madera, California, United States
- Children's Hospital and Research Center at Oakland — Oakland, California, United States
- Kaiser Permanente-Oakland — Oakland, California, United States
- Children's Hospital of Orange County — Orange, California, United States
- Lucile Packard Children's Hospital Stanford University — Palo Alto, California, United States
- Sutter Medical Center Sacramento — Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center — Sacramento, California, United States
- Rady Children's Hospital - San Diego — San Diego, California, United States
- UCSF Medical Center-Parnassus — San Francisco, California, United States
- UCSF Medical Center-Mission Bay — San Francisco, California, United States
- Children's Hospital Colorado — Aurora, Colorado, United States
- Children's Hospital of Alabama — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.